Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Cleveland Clinic expert develops personalized prediction model for Myelodysplastic Syndromes

At the American Society of Hematology Annual Meeting, Cleveland Clinic medical hematologist and oncologist Aziz Nazha, M.D., will present results of a personalized prediction model that surpassed current prediction models for Myelodysplastic Syndromes.

3 Dec 2018

Triple combination cancer immunotherapy improves survival in mouse model of melanoma

Adoptive cell transfer is a promising cancer immunotherapy that involves isolating T cells from cancer patients that are capable of targeting their tumor, selecting the more active T cells and expanding those in the lab, and then transfusing them back into patients.

30 Nov 2018

UA researchers discover promising lead in genetic approach to treating deadly brain cancer

Glioblastoma, a deadly brain cancer that has grabbed headlines for claiming the lives of Sens. Edward Kennedy and John McCain, could be "tricked" into sparing more of its victims.

30 Nov 2018

Study presents new opportunities for targeted, healthy tissue-sparing cancer therapy

Medical physicist Dr. Aswin Hoffmann and his team from the Institute of Radiooncology - OncoRay at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) are the first researchers worldwide to combine magnetic resonance imaging (MRI) with a proton beam, thus demonstrating that in principle, this commonly used imaging method can indeed work with particle beam cancer treatments.

29 Nov 2018

New York State approves NYGC's Whole Genome and Transcriptome Sequencing for oncology

The New York Genome Center has received approval from the New York State Department of Health to offer whole genome and RNA transcriptome sequencing in its Clinical Laboratory Evaluation Program-certified laboratory.

29 Nov 2018

New accelerator-based technology aims to reduce side effects of cancer radiation therapy

New accelerator-based technology being developed by the Department of Energy's SLAC National Accelerator Laboratory and Stanford University aims to reduce the side effects of cancer radiation therapy by shrinking its duration from minutes to under a second.

29 Nov 2018

DNA mutations in healthy and leukemic blood stem cells do not differ, shows research

Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.

29 Nov 2018

Researchers examine the experiences of veterans receiving both cancer treatment and hospice care

Veterans Health Administration hospitals offer something Medicare does not: In some cases, treatments meant to alter the course of a disease can be offered along with hospice care.

28 Nov 2018

UT Southwestern researchers discover enzyme that promotes tumor growth

UT Southwestern researchers have found that an enzyme on the surface of some lung cancer cells helps feed the cancer, making it a tempting treatment target.

28 Nov 2018

Scientists pinpoint protein that plays key role in synovial sarcoma tumors

Researchers have pinpointed a protein that plays a key role in a type of rare cancer often leading to tumours around joints and tendons, according to new findings in eLife.

27 Nov 2018

Research may pave way for development of potent weapons against cancer

Despite significant advances in cancer research, the disease continues to exact a devastating toll. Because cancer is a disease of the body's own cells, which mutate and develop under evolutionary pressure, conventional treatments like chemotherapy and radiation often leave behind a residue of resistant cells that go on to expand and wreak havoc.

27 Nov 2018

Study: Measuring and monitoring tumor DNA can help reveal early melanoma growth

Researchers at the Johns Hopkins Kimmel Cancer Center say they have added to evidence that measuring and monitoring tumor DNA that naturally circulates in the blood of melanoma patients can not only reliably help reveal the early stages of cancer growth and spread but also uncover new treatment options that tumor genetic analysis alone may not.

27 Nov 2018

Researchers identify powerful inhibitor of epigenetic factors that promote acute myeloid leukemia

Some severe forms of leukemia develop because proteins on the epigenetic level lose their regulative function. Now, in a broad international collaboration, UK researchers have identified molecules that can effectively inhibit the dysregulated proteins.

27 Nov 2018

Recently diagnosed cancer patients more likely to drink alcohol and use tobacco, finds study

Recently diagnosed cancer survivors are more likely to drink alcohol, use tobacco, and frequent tanning beds than people in later stages of recovery, according to a research team from the Virginia Tech Carilion Research Institute and Roswell Park Comprehensive Cancer Center.

27 Nov 2018

FDA grants accelerated approval to oncology drug for treatment of key genetic driver of cancer

The U.S. Food and Drug Administration today granted accelerated approval to Vitrakvi (larotrectinib), a treatment for adult and pediatric patients whose cancers have a specific genetic feature (biomarker).

27 Nov 2018

UC San Francisco scientists identify 'Achilles heel' of drug-resistant cancers

UC San Francisco scientists have figured out why some lung cancers become drug-resistant after initially responding to targeted therapies.

27 Nov 2018

Microglia show distinct responses under inflammatory conditions

The NorLux Neuro-Oncology Laboratory at LIH's Department of Oncology conducts research on brain diseases, with a special emphasis on glioma biology, drug resistance and systems approaches.

26 Nov 2018

FDA approves new treatment for AML patients

The U.S. Food and Drug Administration today approved Daurismo (glasdegib) tablets to be used in combination with low-dose cytarabine (LDAC), a type of chemotherapy, for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adults who are 75 years of age or older or who have other chronic health conditions or diseases (comorbidities) that may preclude the use of intensive chemotherapy.

22 Nov 2018

Researchers to develop computer-based tools for use in cancer research

The doctoral program 'CompCancer - Computational Methods in Oncology: Towards Personalized Medicine in Cancer Therapies' has received approval from the German Research Foundation.

21 Nov 2018

Rare Cancers Asia aims to improve patient care

Rare cancers inherently make it difficult to collect data, build clinical expertise and treat affected patients - challenges which are best addressed through collaboration in international networks.

21 Nov 2018

Oncology News and Research

Further Reading

Cleveland Clinic expert develops personalized prediction model for Myelodysplastic Syndromes

Triple combination cancer immunotherapy improves survival in mouse model of melanoma

UA researchers discover promising lead in genetic approach to treating deadly brain cancer

Study presents new opportunities for targeted, healthy tissue-sparing cancer therapy

New York State approves NYGC's Whole Genome and Transcriptome Sequencing for oncology

New accelerator-based technology aims to reduce side effects of cancer radiation therapy

DNA mutations in healthy and leukemic blood stem cells do not differ, shows research

Researchers examine the experiences of veterans receiving both cancer treatment and hospice care

UT Southwestern researchers discover enzyme that promotes tumor growth

Scientists pinpoint protein that plays key role in synovial sarcoma tumors

Research may pave way for development of potent weapons against cancer

Study: Measuring and monitoring tumor DNA can help reveal early melanoma growth

Researchers identify powerful inhibitor of epigenetic factors that promote acute myeloid leukemia

Recently diagnosed cancer patients more likely to drink alcohol and use tobacco, finds study

FDA grants accelerated approval to oncology drug for treatment of key genetic driver of cancer

UC San Francisco scientists identify 'Achilles heel' of drug-resistant cancers

Microglia show distinct responses under inflammatory conditions

FDA approves new treatment for AML patients

Researchers to develop computer-based tools for use in cancer research

Rare Cancers Asia aims to improve patient care

A best-practice guide for laboratory services in oncology trials eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News